Drug Profile
Ezetimibe/rosuvastatin - Biocon
Alternative Names: Rosuvastatin/ezetimibeLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Biocon
- Class Antihyperlipidaemics; Azetidines; Fluorobenzenes; Phenols; Propanols; Pyrimidines; Small molecules; Sulfonamides
- Mechanism of Action Cholesterol absorption inhibitors; HMG-CoA reductase inhibitors; NPC1L1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hypercholesterolaemia
Most Recent Events
- 23 May 2015 No recent reports of development identifed - Phase-III for Hypercholesterolaemia in India (PO)
- 02 Feb 2011 Phase-III clinical trials in Hypercholesterolaemia in India (PO)